BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24136923)

  • 1. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.
    Maguire O; Tornatore KM; O'Loughlin KL; Venuto RC; Minderman H
    Cytometry A; 2013 Dec; 83(12):1096-104. PubMed ID: 24136923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes.
    Noceti OM; Woillard JB; Boumediene A; Esperón P; Taupin JL; Gerona S; Valverde M; Touriño C; Marquet P
    Clin Chem; 2014 Oct; 60(10):1336-45. PubMed ID: 25142246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1.
    Fortin JF; Barbeau B; Robichaud GA; Paré ME; Lemieux AM; Tremblay MJ
    Blood; 2001 Apr; 97(8):2390-400. PubMed ID: 11290602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between pharmacokinetics of tacrolimus and pharmacodynamics on NFAT-regulated gene expression in stable kidney transplant recipients
.
    Keller F; Sommerer C; Giese T; Zeier M; Schröppel B
    Clin Nephrol; 2017 Feb; 87 (2017)(2):93-99. PubMed ID: 28025957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
    Ahmed M; Venkataraman R; Logar AJ; Rao AS; Bartley GP; Robert K; Dodson FS; Shapiro R; Fung JJ; Zeevi A
    Ther Drug Monit; 2001 Aug; 23(4):354-62. PubMed ID: 11477316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic monitoring by residual gene expression of the nuclear factor of activated T cell-regulated genes in lung transplant recipients and its correlation with tacrolimus blood levels.
    Boada-Pérez M; Ruiz de Miguel V; Erro M; Ussetti P; Aguilar M; Castejón R; Rosado S; Escobar-Fornieles R; Revilla-López E; Bravo C; Sáez-Giménez B; Zapata-Ortega M; Villena-Ortiz Y; Vima-Bofarull J; Monforte V; Gómez-Ollés S
    Front Immunol; 2024; 15():1382459. PubMed ID: 38799459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.
    Maguire O; Chen GL; Hahn TE; Brix L; McCarthy PL; Wallace PK; Minderman H
    Methods; 2017 Jan; 112():75-83. PubMed ID: 27327144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
    Bremer S; Vethe NT; Skauby M; Kasbo M; Johansson ED; Midtvedt K; Bergan S
    Br J Clin Pharmacol; 2017 Nov; 83(11):2494-2502. PubMed ID: 28686294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients.
    Sommerer C; Zeier M; Meuer S; Giese T
    Transplantation; 2010 Jun; 89(11):1417-23. PubMed ID: 20463649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1.
    Terui Y; Saad N; Jia S; McKeon F; Yuan J
    J Biol Chem; 2004 Jul; 279(27):28257-65. PubMed ID: 15117942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus.
    Vafadari R; Bouamar R; Hesselink DA; Kraaijeveld R; van Schaik RH; Weimar W; Baan CC; van Gelder T
    Ther Drug Monit; 2013 Aug; 35(4):459-65. PubMed ID: 23743668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo.
    Fehr T; Lucas CL; Kurtz J; Onoe T; Zhao G; Hogan T; Vallot C; Rao A; Sykes M
    Blood; 2010 Feb; 115(6):1280-7. PubMed ID: 20007805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced residual gene expression of nuclear factor of activated T cells-regulated genes correlates with the risk of cytomegalovirus infection after liver transplantation.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Transpl Infect Dis; 2014 Jun; 16(3):379-86. PubMed ID: 24666466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of tacrolimus on p38 mitogen-activated protein kinase signaling in kidney transplant recipients measured by whole-blood phosphospecific flow cytometry.
    Vafadari R; Hesselink DA; Cadogan MM; Weimar W; Baan CC
    Transplantation; 2012 Jun; 93(12):1245-51. PubMed ID: 22643331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
    Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
    Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTD-mediated intracellular delivery of mutant NFAT minimum DNA binding domain inhibited the proliferation of T cells.
    Liu X; Zhao Q; Peng X; Xia S; Shen W; Zong Y; Cheng J; Wu W; Zhang M; Du F; Xu W; Qian H; Shao Q
    Int Immunopharmacol; 2014 Mar; 19(1):110-8. PubMed ID: 24440534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic disparities in tacrolimus-treated patients developing cytomegalus virus viremia.
    Sommerer C; Zeier M; Czock D; Schnitzler P; Meuer S; Giese T
    Ther Drug Monit; 2011 Aug; 33(4):373-9. PubMed ID: 21743376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial.
    Kannegieter NM; Hesselink DA; Dieterich M; de Graav GN; Kraaijeveld R; Baan CC
    Sci Rep; 2017 Nov; 7(1):15135. PubMed ID: 29123208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy Volunteers.
    Djaelani YA; Giese T; Sommerer C; Czock D
    Ther Drug Monit; 2023 Feb; 45(1):87-94. PubMed ID: 36191295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.